Invagen Pharmaceuticals, Inc.
Invagen Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 48 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Invagen Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/invagen-pharmaceuticals-inc
Overview
Invagen Pharmaceuticals, Inc. is a leading pharmaceutical company that focuses on the development, manufacture, and distribution of generic medicines. As a subsidiary of the global pharmaceutical company Cipla Limited, Invagen is committed to providing affordable healthcare solutions worldwide.
Core services & business areas
FDA compliance signals
48 FDA enforcement records linked to this company.
- recall — Class I2024-01-17
Defective Container: powder may leak out of the pouch
- recall — Class III2020-05-27
Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
- 4832019-12-06
Testing and release for distribution
- 4832019-12-06
Written in-process control procedures
- 4832019-12-06
Batch production and Batch Control Record Requirements
- recall — Class III2019-07-10
Defective Container; actuator may improperly function and affect dose delivery.
- recall — Class II2019-04-24
Presence of Particulate Matter.
- recall — Class II2019-04-24
Presence of Particulate Matter.
- recall — Class II2019-04-24
Presence of Particulate Matter.
- recall — Class III2018-10-17
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
- recall — Class III2018-09-26
Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size.
- 4832018-05-25
Scientifically sound laboratory controls
- 4832018-05-25
Failure to meet specifications
- 4832018-05-25
Mix-up
- 4832018-05-25
Investigations of discrepancies, failures
- 4832018-05-25
Backup file not maintained
- 4832018-05-25
Written program not followed
- recall — Class III2018-04-18
Failed impurities/degradation specifications: Failure to water content and impurity
- recall — Class III2018-04-11
Failed Dissolution Specifications; during stability testing
- recall — Class III2018-04-11
Failed Dissolution Specifications; during stability testing
- 4832015-05-26
Procedures not in writing, fully followed
- 4832013-03-08
Control procedures to monitor and validate performance
- 4832013-03-08
Procedures not in writing, fully followed
- 4832013-03-08
Valid stability test methods
- 4832012-06-14
Handling and Storage to Prevent Contamination
- 4832012-03-02
Procedures for non-sterile drug products
- 4832012-03-02
Investigations of discrepancies, failures
- 4832011-04-13
Written procedures not established/followed
- 4832011-04-13
Scientifically sound laboratory controls
- 4832011-04-13
Procedures not in writing, fully followed
- 4832011-04-13
Returned drug procedures in writing and followed
- 4832010-11-10
Sampling and testing plans not described
- 4832010-11-10
Complete instructions, procedures, specifications et. al.
- 4832010-11-10
Reprocessing procedures not written or followed
- 4832010-11-10
Failure to meet specifications
- 4832010-11-10
Complaint Handling Procedure
- 4832010-11-10
Procedures not in writing, fully followed
- 4832010-11-10
Procedures To Be in Writing
- 4832010-11-10
In-process samples representative, identified properly
- 4832010-08-27
Procedures not in writing, fully followed
- 4832010-08-27
Written record of investigation incomplete
- 4832010-08-27
Failure to meet specifications
- 4832009-05-12
Written procedures not established/followed
- 4832009-05-12
Procedures To Be in Writing
- 4832009-05-12
SOPs not followed / documented
- 4832009-05-12
Non-applicant reports directly to FDA
- 4832009-05-12
Incomplete periodic safety report
- 4832009-05-12
Wrong form - domestic ADE
Is this Invagen Pharmaceuticals, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.